Skip to main content
Clinical Trials/DRKS00007786
DRKS00007786
Completed
未知

Clinical study on the effectiveness of three products in the treatment of herpes simplex labialis

Sylphar NV0 sites180 target enrollmentJune 16, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
B00.1
Sponsor
Sylphar NV
Enrollment
180
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2015
End Date
October 24, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sylphar NV

Eligibility Criteria

Inclusion Criteria

  • Male and female patients in the age of 18 till 65 years
  • Written approval of the participant person after clarification
  • Healthy probands, Probands with a finished therapy, without a hurtful tooth or mucosa illness
  • Acute Herpes Simplex labialis

Exclusion Criteria

  • Signs that the patient is unable to comply with the test plan (eg lack of cooperation)
  • Probands with severe general medical disorders
  • The taking of antibiotic or antiphlogistic drugs in the last two weeks prior to study entry
  • The taking of anti\-inflammatory drugs during the study period
  • oral diseases, for example Ulcerative gingivitis (NUG), periodontitis colitis (NUP)
  • Immune systeme disorders
  • Known hypersensitivity to the substances used in the study
  • Pregnangcy or lactation
  • Alcohol or drug abuse in the recent past or last year
  • An employee of the sponsor or the study, or a member of their close Family

Outcomes

Primary Outcomes

Not specified

Similar Trials